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Dutch elm disease fungus Ophiostoma novo-ulmi contains a
hydrolase activity which catalyses the resolution of racemic ethyl
naproxen to the corresponding acid. The recombinant enzyme has
been crystallized by the vapour-diffusion method in two crystal forms.
The crystals of the ®rst form belong to space group P21212, with unit-
cell parameters a = 115.9, b = 174.4, c = 62.1 AÊ . The enzyme also
crystallizes in space group P21212, with unit-cell parameters a = 72.9,
b = 212.7, c = 61.7 AÊ . Synchrotron data have been collected for both
crystal forms to 2.6 and 2.3 AÊ , respectively. A molecular-replacement
solution has been found using a remote starting model of a bacterial
esterase (23% sequence identity) for both crystal forms. Multicrystal
averaging has resulted in interpretable electron-density maps.
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1. Introduction
Hydrolases are a large family of enzymes that
are responsible for the degradation of amide-
and ester-type bonds in a wide range of
substrate molecules. These enzymes can utilize
a variety of natural and unnatural substrates
and this has led to their use as stereoselective
catalysts in the synthesis of optically pure
molecules for the pharmaceutical and agro-
chemical industries (Faber, 1997). Esterases
are part of the hydrolase family and are
ubiquitous enzymes, having been identi®ed in
eukaryotes, bacteria and archaeal species.
A novel hydrolase was isolated from the
fungus Ophiostoma novo-ulmi, the causative
agent of Dutch elm disease. The 435-amino-
acid enzyme has a molecular mass of 47 601, a
predicted pI of 5.44 and is capable of catalysing
the resolution of racemic ethyl naproxen.
Naproxen, like ketoprofen and ibruprofen,
is a 2-arylpropionoic acid that acts as a
non-steroidal anti-in¯ammatory drug in the
treatment of arthritis and other related
connective-tissue diseases. S-Naproxen has
been shown to be the active isomer. Optically
pure naproxen can be produced by chemical
methods that are generally complicated and
costly (Fadel, 1992). The so-called `naproxen
esterase' described in this paper is capable of
utilizing S-ethyl naproxen as a substrate with
98% enantiomeric excess.
Characterization of this esterase (Brindley,
1998) shows that this enzyme is not inhibited
by phenylmethylsulfonyl ¯uoride (PMSF), an
irreversible inhibitor of serine hydrolase
enzymes. The enzyme belongs to the esterase
family VIII (Arpigny & Jaeger, 1999) and has a
sequence similarity to penicillin-binding
proteins. These latter enzymes bind or react
with penicillin and other -lactam antibiotics
and do not possess a classical catalytic triad of
Ser-His-Asp-(Glu), but have a Ser-X-X-Lys
motif where serine is the catalytic residue
(Kelly et al., 1985).
A structure has been elucidated recently of
another representative of the esterase VIII
family: EstB from Burkholderia gladioli
(Wagner et al., 2002). This enzyme shares 23%
sequence identity with O. novo-ulmi esterase
and has a tertiary structure similar to that of
penicillin-binding proteins. Although EstB
shares some active-site residues with penicillin-
binding proteins, it shows no catalytic activity
towards the -lactam ring (Petersen et al.,
2001). This has been attributed to the differ-
ence in shape of the active-site tunnel (Wagner
et al., 2002).
Here, we report the puri®cation, crystal-
lization and preliminary X-ray analysis of the
naproxen esterase.
2. Materials and methods
2.1. Protein purification
A -phage expression library of the O. novo-
ulmi cDNA was made in Escherichia coli and
initially screened for ability to use S-ethyl
ketoprofen as a substrate. The resultant gene
was then subjected to mutagenesis with
hydroxylamine and screened for the ability to
use S-ethyl naproxen as a substrate. This was
monitored by the appearance of clearing zones
of the emulsi®ed substrate overlaid on an agar
plate. The positive colonies were picked from
the plate and the resultant naproxen esterase
gene was overexpressed in E. coli using two
different expression systems: pKK233-2
(Amersham Biosciences) and a variant of
crystallization papers
pUC19. This work was carried out at
Chiroscience, Cambridge Science Park, UK
in collaboration with Dr Richard Wisdom.
The E. coli cells harbouring the naproxen
esterase gene were lysed with lysozyme
[0.1%(w/v) in lysis buffer: 0.1 M sodium
bicarbonate, 10 mM EDTA, 1% Triton
X-100 pH 9] by shaking for 4 h at room
temperature. Polyethylenimine (0.25% ®nal
concentration) was added to remove the
nucleic acids and the lysed cells were shaken
for a further 30 min. After centrifugation to
remove the cell debris, the resultant super-
natant was dialysed against 10 mM Bicine,
0.2 mM EDTA pH 8.5 (buffer A).
A 30% ammonium sulfate (enzyme-
grade) precipitation step was used to remove
unwanted protein and the supernatant was
dialysed against buffer A. This was then
adjusted to 20% (NH4)2SO4 before appli-
cation onto a benzamidine Sepharose af®-
nity column (Sigma) equilibrated in the
same buffer. The naproxen esterase was
eluted with a negative linear gradient of 20±
0% (NH4)2SO4 in buffer A over one column
volume.
Esterase activity was detected using the
p-nitrophenyl acetate assay (Sobek &
Gorisch, 1988) and the purity of the protein
was assessed by SDS±PAGE (Laemmli,
1970). Active fractions were precipitated
with 80% (NH4)2SO4. The resulting pellet
was resuspended in a minimum of 10 mM
HEPES, 0.2 mM EDTA pH 7.2 (buffer B)
and dialysed against the same buffer. The
dialysed sample was loaded onto a pre-
packed Pharmacia MonoQ anion-exchange
column 5/5 equilibrated with buffer B.
Protein was eluted with a linear gradient of
0±0.5 M NaCl over 20 column volumes. The
esterase activity was eluted at 0.3 M NaCl
and these active fractions were pooled and
concentrated by the addition of 80%
(NH4)2SO4. The resultant pellet was resus-
pended in a minimal amount of buffer A
with 5% (NH4)2SO4. After centrifugation,
the supernatant was applied onto a pre-
packed Pharmacia Superose 12 column
(3.5  30 cm) equilibrated in buffer A with
5% (NH4)2SO4. Active fractions from this
®nal step were pooled and concentrated
using Amicon Centricons (10 kDa cutoff).
The puri®ed enzyme was subjected to
sedimentation-equilibrium and velocity
analysis (NCMH, Universities of Notting-
ham and Leicester) to determine the oligo-
meric state of the protein and laser-
desorption mass spectrometry (University of
Aberdeen, Protein Sequencing Facility) to
assess the protein homogeneity and subunit
mass.
2.2. Crystallization
Crystallization was carried out by the
vapour-diffusion method at 290 K. A wide
screen of precipitants was used as a preli-
minary step to determine conditions from
which crystals would grow. These included
ammonium sulfate with 10 mM Bicine pH
8.5, 20 mM Tris±HCl pH 8.0 and 10 mM
HEPES pH 7.5 with protein concentrations
of between 10 and 15 mg mlÿ1, polyethylene
glycols 400 and 600 in 10 mM Bicine pH 8.5
and 10 mM HEPES pH 7.5 with protein
concentrations of 15±20 mg mlÿ1 and
Crystal Screen I and II (Hampton Research,
USA) with protein at 10 mg mlÿ1. Crystals
were set up initially as 5 ml hanging drops
and later as sitting drops.
In order to improve the quality of the
crystals grown from ammonium sulfate the
protein concentration and pH were varied
and additives were tested by adding 10% of
different Crystal Screen I reagents to a
reservoir of 35% ammonium sulfate in
Bicine buffer. The best crystals grown from
35% ammonium sulfate and 0.5% PEG 4000
as an additive were further optimized by
varying the protein concentration. Crystal
size was improved by employing an oil
barrier (Chayen, 1997) spread onto the
reservoir prior to positioning the cover slip.
The oil barrier used was 35% paraf®n oil/
65% silicone ¯uid in 500 ml.
The second crystal form of the enzyme
was grown from 38% saturated sodium
malonate in 100 mM Bicine buffer pH 9.0.
The crystals were improved by screening the
addition of organic additives to the reser-
voir. The best crystals were grown by the
addition of 3% ethanol or ethylene glycol.
2.3. Crystallographic data collection
For X-ray data collection, the crystals of
®rst form were harvested into a cryo-
protectant of 45% ammonium sulfate, 25%
glycerol, 10 mM Bicine pH 8.5. Native data
were collected at 100 K at beamline 7.2 of
the Daresbury Synchrotron source from a
single crystal at a wavelength of 1.488 AÊ .
Putative derivative data were collected at
EMBL station BW7B, DESY Synchrotron
Hamburg on two crystals soaked in cryo-
protectant containing either 5 mM uranyl
acetate for 1 h or 10 mM mercury acetate for
4 h.
Crystals of the second crystal form were
harvested into cryoprotectant containing
50% saturated sodium malonate in 100 mM
Bicine buffer pH 9.0. Native data were
collected at 100 K from a single crystal at
Max-Planck Institute station BW6, DESY
Synchrotron Hamburg at a wavelength of
1.05 AÊ . The data were collected on EMBL
station BW7A from a crystal soaked for 1 h
in cryoprotectant containing 10 mM mer-
cury acetate. All data were processed using
the programs DENZO and SCALEPACK
(Otwinowski & Minor, 1997).
3. Results and discussion
The naproxen esterase eluted as a single
peak from the gel-®ltration column and
appeared to run as a single band on SDS±
PAGE with an apparent molecular weight of
44 kDa.
Crystallization trials carried out with
enzyme expressed from the pUC19 variant
plasmid were unsuccessful. A sample of this
protein, pure with respect to SDS±PAGE,
exhibited two protein species, one of
48 288 kDa and one of 47 456 kDa, present
in a 7:3 ratio when examined by mass spec-
trometry. N-terminal sequencing deter-
mined that part of the pUC19 plasmid had
been transcribed upstream of the naproxen
esterase gene. As a consequence, the sample
contained two protein species that were
essentially identical, only differing by nine
amino acids at the N-terminus. This
phenomenon may have resulted from either
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Table 1
Processing statistics for the native data sets from the two different crystal forms.
Values in parentheses are for the highest resolution shell.
Crystal A Crystal B
Space group P21212 P21212
Unit-cell parameters (AÊ ) a = 115.9, b = 174.4,
c = 62.1
a = 72.9, b = 212.7,
c = 61.7
Resolution range (AÊ ) 25±2.6 (2.64±2.6) 20±2.32 (2.36±2.32)
No. measured re¯ections 97261 136392
No. unique re¯ections 36757 40786
Completeness 92.6 (85.6) 95.7 (94.7)
I > 2(I) (%) 74.7 80.4
hIi/hIi 6.8 16.7
Rsym² (%) 14.1 (48.9) 6.5 (25.1)
² Rsym =
P jI ÿ hIij=P I, where I is the intensity of the re¯ection.
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two separate translation reactions or from
post-translational proteolysis of the extra
nine amino acids.
Naproxen esterase expressed from the
pKK233-2 expression system was shown to
be a single species by N-terminal sequencing
and sedimentation-equilibrium and velocity
analysis. The protein was determined to
be a monomer of 47 179  340 Da. Initial
crystallization trials produced clusters
of very ®ne needles from 34±36%
(NH4)2SO4,10 mM Bicine pH 8.5. Larger
crystals were grown using 0.5% PEG 4000 as
an additive. Oil barriers spread over the
reservoir reduced the amount of clustering,
which allowed the growth of single crystals.
Rod-like crystals achieved dimensions of
0.7  0.2  0.1 mm.
The heterogeneity of protein samples
expressed from the pUC19 variant plasmid
is believed to have prohibited crystallization.
A naproxen esterase sample that was shown
to be homogeneous crystallized readily. This
is in agreement with observations by
Abergel et al. (1991) that nucleation of
turkey egg-white lysozyme is inhibited by
controlled contamination with hen and quail
lysozyme.
The native data for the ®rst crystal form
were collected to 2.6 AÊ (Table 1). The
crystals belong to the orthorhombic space
group P21212, with unit-cell parameters
a = 115.9, b = 174.4, c = 62.1 AÊ . The solvent
content of the crystals, which contain two
molecules in the asymmetric unit, has been
estimated at 62% (VM = 3.3 AÊ Da
ÿ1;
Matthews, 1968).
To obtain an improved cryoprotectant,
the protein was crystallized from sodium
malonate, which produced the second crystal
form, which grew to dimensions of 0.8 0.15
 0.1 mm. These crystals belong to space
group P21212, with unit-cell parameters
a = 73.0, b = 212.7, c = 61.7 AÊ . The native
data from this crystal form have been
collected to 2.3 AÊ (Table 1). The solvent
content of the crystals, which contain two
molecules in the asymmetric unit, has been
estimated at 51% (VM = 2.5 AÊ Da
ÿ1).
The self-rotation function calculated for
both crystal forms did not show any signi®-
cant features (data not shown). The simi-
larity of the unit-cell parameter c between
the two lattices suggests that the two unit
cells might be related. To check this
hypothesis, the cross-rotation function was
calculated between the two native data sets
using the BLANC complex of crystallo-
graphic programs (Vagin et al., 1998). The
cross-rotation function showed strong
features at section  = 0, ÿ  = 47 (Fig. 1).
This indicates that molecules in the two
crystal lattices are related by a rotation of
47 around the crystallographic z axis.
Crystal non-isomorphism in both crystal
forms prevented the use of the MIR
approach for structure solution. Initial
attempts to use molecular replacement
(MR) with either the d-alanyl-d-alanine
carboxypeptidase (Kelly et al., 1985;
sequence identity 14%) or the E. coli Ampc
-lactamase (Patera et al., 2000; sequence
identity 16%) as a model failed to ®nd a
solution which could be re®ned further.
When a monomeric model of EstB from
B. gladioli (Wagner et al., 2002), which
shares 23% sequence identity with the
naproxen esterase, became available the
program MOLREP (Vagin & Teplyakov,
1997) was used for MR. The correct MR
solutions for two naproxen esterase mono-
mers in the asymmetric unit of the ®rst
crystal form were found only when a new
FILE_SEQUENCE option of MOLREP
was used. When this option is activated
MOLREP reads the sequence of the target
structure and truncates the search model
according to the sequence alignment.
Default values were used for other
MOLREP options. The correct rotation-
function peaks were the third and twelfth in
the rotation-function list. Subsequent MR
studies have shown that the sequence-based
truncation of the model only marginally
improved the contrast for the translation
search. However, without this truncation the
correct solution for one of the two molecules
was not amongst the highest 200 peaks of the
rotation function.
The EstB model positioned in the ®rst
crystal form was subjected to 100 cycles of
positional and B-factor re®nement in
REFMAC (Murshudov et al., 1997). Al-
though Rfree did not improve during the
course of this re®nement, the output model
was successfully used for MR in the second
crystal form. The MR solution could not be
found for this crystal form with the unre-
®ned EstB model. Multicrystal averaging
using the program DMMULTI (Cowtan &
Main, 1998; Collaborative Computational
Project, Number 4, 1994) produced an
interpretable electron-density map. The
atomic models have been re®ned by
REFMAC in both crystal forms to an Rfree of
below 30%.
The asymmetric unit of each crystal form
contains a naproxen esterase dimer. The
r.m.s. deviation of the C-atom positions
between the dimers in the two different
crystal forms is only 1.13 AÊ . However, the
two monomers in the naproxen esterase
dimer are not related by a dyad, but by a
rotation of 139. As was originally suggested
from the cross-rotation function, the dimers
in two crystal forms are related by a rotation
of 47 around the crystallographic z axis.
One subunit of the dimer in the second
crystal form is signi®cantly less ordered than
the other subunit. This could explain the
earlier failure to ®nd the translation-
function solution in this crystal form using
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Figure 1
 = 0 section of the cross-rotation function
calculated between the data from the two crystal
forms of naproxen esterase. The calculations were
perfomed with an integration radius of 30 AÊ at 14±
3 AÊ resolution using the program suite BLANC
(Vagin et al., 1998). The strong feature at  ÿ  = 47
indicates that molecules in the two crystal lattices are
related by a rotation around the crystallographic z
axis.
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the relationship between the two crystal
forms.
Although macromolecules often crystal-
lize in several crystal forms, a cross-rotation
function between the data is not routinely
calculated. It would appear that use of the
cross-rotation function calculated between
data sets in different lattices could bene®t
dif®cult phasing problems when one of the
lattices is triclinic and contains a single
biological unit. The cross-rotation function
calculation could also be useful for higher
symmetry crystal lattices in instances when
there is a putative relationship between their
unit-cell parameters. Naproxen esterase is
an example of a case where the cross-
rotation function calculated for data in the
two orthorhombic lattices has provided
useful information about the relative
arrangement of the molecules between the
two crystal forms prior to structure solution.
We are currently re®ning the structure of
the naproxen esterase in order to under-
stand the relationship of this enzyme to
-lactamases. Experiments to soak or co-
crystallize the naproxen esterase with
substrates/inhibitors are under way in order
to de®ne the enzyme's active site and its
substrate speci®city.
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